Viewing StudyNCT00047346



Ignite Creation Date: 2024-05-05 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00047346
Status: COMPLETED
Last Update Posted: 2013-01-23
First Post: 2002-10-03

Brief Title: Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-08
Start Date Type: None
Primary Completion Date: 2005-12
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2002-10-03
First Submit QC Date: January 26 2003
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-01-22
Last Update Post Date: 2013-01-23
Last Update Post Date Type: ESTIMATED